TRPC3 and Sepsis: Since the development of new pharmacological strategies that use TRPC3 as a target are well advanced, and we have observed that selective inhibition of TRPC3 reduces inflammation in a murine sepsis model, our study provides the foundation for new therapies against inflammatory-based diseases using drugs targeting this channel.